IMMUNE THERAPEUTICS THAT COMBINE FAST-ACTING MONOCLONAL ANTIBODY AND A VACCINE FOR LONG-LASTING PROTECTION AGAINST PLASMODIUM FALCIPARUM MALARIA

$1,672,094FY2022Defense Health AgencyDOD

The Geneva Foundation

Investigators